The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

All 16 of Indiana’s designated senior care organizations are now required to have a dementia outreach specialist. The goal is ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, particularly in women. Levels were found to drop gradually, from women with ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...